- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01030276
Bright Light Therapy in Seasonal Affective Disorder (SAD) (VAHAVA)
December 10, 2009 updated by: University of Oulu
Placebo-controlled, Double Blind RCT on the Efficacy of Bright Light Therapy in SAD
The aim of this study is to investigate the efficacy of bright light therapy in SAD.
This is a placebo-controlled, double-blind randomized controlled trial (RCT).
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Markku J Timonen, Prof
- Phone Number: +358 40 8324883
- Email: markku.timonen@oulu.fi
Study Locations
-
-
-
Oulu, Finland, FIN-90100 Oulu
- Recruiting
- Research unit, ODL Terveys Oy, Albertinkatu 18 A
-
Contact:
- Markku J Timonen, Prof
- Phone Number: + 358 40 8324883
- Email: markku.timonen@oulu.fi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- a patient has, according to the DSM-IV-TR, a Major depression, recurrent episode, seasonal pattern, "moderate" or "severe" (classification code 296.32 and 296.33)
- HAMD-21 (included in the SIGH-SAD) sum score is ≥ 22
- patient is over 18 years
- patient can read and understand the subject information sheet
- patient has signed the informed consent form
- patient is not pregnant
Exclusion Criteria:
- patient has a lifetime psychotic disorder
- patient has a DSM-IV Axis I disorder other than some anxiety disorder evaluated by MINI
- patient has some DSM-IV-TR Axis II disorder, which is likely to interfere with the study treatment according to the investigator
- patient has alcohol or some other substance use dependence or misuse
- life-time suicide attempt, or any thought of suicide during the last month
- patients has some unstable somatic disorder
- patient uses some medication on regular basis
- patient uses some herbal psychotropic agencies
- patient is, in the opinion of the investigator, unsuitable for any reason
- patient is a member of the site personnel or their immediate families
- patient has had bright light therapy during the current episode
- patient has some eye disease (patient can, however, be myopic or hyperopic)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Bright light
|
Bright light therapy
|
Placebo Comparator: Inactive "placebo-light"
|
In this arm, patients will not get any bright-light therapy in a double-blind setting
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Remission as defined by the SIGH-SAD
Time Frame: 28 (visit window from 26 to 30 days) days after the inclusion day
|
28 (visit window from 26 to 30 days) days after the inclusion day
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Decrease of the severity of symptoms as assessed by SIGH-SAD, Hamilton anxiety scale, and Beck depression inventory-21
Time Frame: 28 (visit window from 26 to 30 days) days
|
28 (visit window from 26 to 30 days) days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2009
Primary Completion (Anticipated)
March 1, 2011
Study Completion (Anticipated)
April 1, 2011
Study Registration Dates
First Submitted
December 10, 2009
First Submitted That Met QC Criteria
December 10, 2009
First Posted (Estimate)
December 11, 2009
Study Record Updates
Last Update Posted (Estimate)
December 11, 2009
Last Update Submitted That Met QC Criteria
December 10, 2009
Last Verified
December 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FI (FWA00000190) 11/2008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Seasonal Affective Disorder
-
GlaxoSmithKlineCompleted
-
University of OuluCompletedSeasonal Affective Disorder (SAD)Finland
-
University Medical Center GroningenCompletedSeasonal Affective DisorderNetherlands
-
University of VermontNational Institute of Mental Health (NIMH)CompletedSeasonal Affective Disorder (SAD) | Winter Depression | Major Depressive Disorder, Recurrent, With Seasonal PatternUnited States
-
Medical University of ViennaCompletedSeasonal Affective DisorderAustria
-
Thomas Jefferson UniversityApollo Health SystemsCompletedSeasonal Affective DisorderUnited States
-
University of VermontUniversity of Pittsburgh; University of Maryland School of MedicineActive, not recruitingSeasonal Affective DisorderUnited States
-
ProofPilotJoovvCompletedSeasonal Affective DisorderUnited States
-
Yale UniversityUniversity of British Columbia; McGill University Health Centre/Research Institute... and other collaboratorsCompletedSeasonal Affective DisorderUnited States, Canada, Netherlands
-
University of OuluOulu University Hospital; University of Eastern Finland; ODL Terveys Oy; Valkee OyCompleted
Clinical Trials on Bright light therapy
-
VA Office of Research and DevelopmentRecruiting
-
Maimonides Medical CenterFoundation for Prader-Willi ResearchRecruitingBody Weight | Hyperphagia | Prader-Willi Syndrome | Mood | Behavior | Excessive Daytime SleepinessUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingBladder Carcinoma | Kidney Carcinoma | Prostate Carcinoma | Genitourinary System NeoplasmUnited States
-
Chinese University of Hong KongRecruiting
-
Erasmus Medical CenterNot yet recruiting
-
M.D. Anderson Cancer CenterTerminatedAdvanced CancersUnited States
-
Medical University of ViennaNational Bank of AustriaUnknownMultiple Sclerosis | FatigueAustria
-
State University of New York at BuffaloOncology Nursing SocietyUnknownFatigue | Sleep Disturbance | Circadian DysregulationUnited States
-
Sunnybrook Health Sciences CentreCompletedMajor Depressive Disorder | Seasonal Affective Disorder | NeuroimagingCanada
-
Hospital Authority, Hong KongUnknown